因为Plos one和Scientific Report每年出刊超过1万篇,我们没有计算出影响因子,望有经验者提供指导,如果可以计算的话,我们会在后续文章中分享给大家。 EMBO杂志的分数大概9分多,几个杂志的分数基本稳定, EMBO Molecular Medicine 2020年应该会涨到10分。以前10分的杂志很少,所以EMBO杂志比较有影响力,而现在10分以上杂志...
自1975年以来,影响因子(Impact factor,缩写IF)每年定期发布于“期刊引用报告”(Journal Citation Reports,JCR)为文献计量学的发展带来了一系列重大革新。IF 仅在一定程度上代表了学术期刊的水平,并不能直接代表期刊上具体某篇论文的水平。今年的“期刊引用报告”计算方法有所变化,把在线发表内容引入2021年 JCR(2020年...
with editorial decisions being made by an in-house team, although peer review by external expert referees forms a part of the review process. Nature Medicine is published monthly. Articles are archived online in text and PDF formats; access is by subscription only. Its 2010 impact factor was ...
表2 精神病学领域期刊 2022、2021IF 2021年影响因子≥10分的期刊有18种,期刊Asian Journal of Psychiatry(13.890→9.5), Evidence-Based Mental Health(13.538→5.2), NEUROPSYCHOBIOLOGY(12.329→3.2), International Journal of Mental Hea...
Nature Medicine thanks Agustin Ibanez, Josiah Kephart and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Primary Handling Editor: Ming Yang, in collaboration with the Nature Medicine team. Additional information Publisher’s note Springer Nature remains neu...
Atom RSS Feed Predictive markers articles within Nature Medicine Featured Article 30 January 2025 | Open Access Plasma proteomic evidence for increased β-amyloid pathology after SARS-CoV-2 infection Blood biomarkers in a middle-aged population suggest that SARS-CoV-2 infection is associated with...
Cell 旗下的 OA 期刊 Cell Reports 去年 IF 冲到 9.995,今年却没有出现在榜单中。Cell Reports Medicine 今年 IF 为 14.3,成绩非常不错。 整体上,大部分 OA 期刊的影响因子仍然很低,OA 出版之路仍需继续探索。 3.国产期刊势头强劲 Cell Research, 44.1 (2021, 46.297),排名前50; ...
for Therapy Choice (NCI-MATCH,NCT02465060) studies in adults and a study (NCT02124772) in pediatric patients with refractory or recurrent solid tumors. This was the first approval for a tumor-agnosticBRAFandMEKinhibitor combination approach and was a considerable advance in precision medicine. ...
Biotechnology 2021 Q1 Biotechnology 2022 Q1 Biotechnology 2023 Q1 Molecular Medicine 1999 Q1 Molecular Medicine 2000 Q1 Molecular Medicine 2001 Q1 Molecular Medicine 2002 Q1 Molecular Medicine 2003 Q1 Molecular Medicine 2004 Q1 Molecular Medicine 2005 Q1 Molecular Medicine 2006 Q1 Molecular Medicine 2007 ...
Systemically glucocorticoid medicine ≥15 mg per day within 7 days before apheresis; inhalations containing corticosteroids are not excluded. 7. Patient allergic or intolerant to preconditioning drugs, including, but not limited to, fludarabine and cyclophosphamide or tocilizumab; allergic to the comp...